Take-Two Interactive Software Inc. stock underperforms Friday when compared to competitors
This was the stock's third consecutive day of losses.
Protara Therapeutics: Speculative Buy On Promising TARA-002 Trial Results
TARA’s leading candidate is TARA-002, which so far looks like a promising immune-stimulating therapy derived from OK-432 ...
PharmiWeb13h
LillyDirect platform expands to facilitate access to Alzheimer's disease care
Eli Lilly and Company (LLY) has expanded its LillyDirect digital healthcare platform to offer connections to independent ...
AARP15h
AARP Is Fighting to Protect Your Social Security
Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Send a loud and clear message to your lawmakers NOW and join AARP ...